Press release
Epilepsy Drugs Market Grows with Novel ASMs and Increased Diagnosis in Emerging Markets | Novartis AG, Hoffmann-La Roche Limited, Pfizer Inc., UCB, Inc.
Epilepsy Drugs Market
Epilepsy Drugs Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With increasing prevalence of epilepsy, the development of targeted therapies, and improved access to antiepileptic drugs, the report delivers strategic insights for stakeholders in the neurological disorder treatment sector from 2025 to 2033.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/epilepsy-drugs-market?ophp
Epilepsy drugs (antiepileptic drugs or AEDs) are used to control seizures in individuals with epilepsy. The market includes both branded and generic options, with new entrants focusing on fewer side effects and better seizure control. Precision medicine, neurostimulation devices, and alternative therapies are also contributing to this market's evolution.
Epilepsy Drugs Market Competitors Overview:
Novartis AG, Hoffmann-La Roche Limited, Pfizer Inc., UCB, Inc., Sumitomo Pharma America, Inc., Camber Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc., AdvaCare Pharma, Zydus Healthcare Limited, among others.
Important Industry Updates of 2025:
✅ In February 2025, Biogen Inc. and Stoke Therapeutics, Inc. announced a collaboration to develop and commercialize zorevunersen in all regions outside the U.S., Canada, and Mexico. Zorevunersen is an investigational antisense oligonucleotide (ASO) designed to target the SCN1A gene, which is the primary cause of most Dravet syndrome cases.
Methodology and Scope
The Epilepsy Drugs Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/epilepsy-drugs-market?ophp
Epilepsy Drugs Market Segments Overview:
∎ By Type (Generalized Seizures, Focal Seizures, Others)
∎ By Treatment (Narrow-spectrum Antiepileptic Drugs, Broad-spectrum Antiepileptic Drugs)
∎ By Route of Administration (Oral, Parenteral)
The second-generation antiepileptic drugs segment dominates thanks to improved safety profiles, fewer drug interactions, and effectiveness in various seizure types.
Regional Overview for Epilepsy Drugs Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
North America accounts for the largest share of the epilepsy drugs market, benefiting from high awareness, access to advanced therapies, and consistent diagnosis rates. Asia Pacific is growing rapidly as healthcare access improves and awareness campaigns expand.
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=epilepsy-drugs-market?ophp
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the Epilepsy Drugs market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Epilepsy Drugs market?
Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epilepsy Drugs Market Grows with Novel ASMs and Increased Diagnosis in Emerging Markets | Novartis AG, Hoffmann-La Roche Limited, Pfizer Inc., UCB, Inc. here
News-ID: 4129553 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Orthopaedic Implants Market to Reach USD 71.6 billion by 2030, Dri …
The global Orthopaedic Implants Market reached USD 44.7 billion in 2022 and is projected to reach USD 71.6 billion by 2030, growing at a CAGR of 6.2% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, Zimmer Biomet raised its annual profit forecast, driven by strong demand for hip and knee implants and advancements in robotic-assisted surgical systems.
✅ In August 2025, Exactech…
United States Viral Inactivation Market 2025 | Growth Drivers, Key Players & Inv …
Market Size and Growth
Viral Inactivation Market is expected to grow at a CAGR of 11.0% during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In May 2025, the U.S. Centers for Disease Control and Prevention (CDC) reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. The incidence rate also rose from 2.5 per 100,000 individuals in 2022…
Bone Broth Protein Market Outlook 2025-2032
The global bone broth protein supplement market reached US$89.99million in 2024 and is expected to reach US$165.34million by 2032, growing at a CAGR of 7.9% during the forecast period 2025-2032.
The market includes protein supplements made from simmered animal bones, rich in collagen, supporting joint, muscle, skin, and gut health, driven by demand for natural, functional nutrition.
📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Bone Broth…
Nebulizer Market Growth & Trends 2025-2033
The global inhalation therapy nebulizer market was valued at US$1.15 B in 2024 and is projected to reach US$4.52 B by 2033, growing at a CAGR of 7.8% from 2025 to 2033.
The market covers devices that deliver medication as a mist directly into the lungs to treat respiratory diseases like asthma, COPD, and cystic fibrosis. Growth is driven by rising respiratory disorders, technological innovations, and expanding healthcare access.
📌 Download Sample…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
